Source: Ilya Sutskever's startup Safe Superintelligence is raising $1B+ at a $30B+ valuation led by Greenoaks Capital, which plans to invest $500M
that outsmarts humans in a safe way—is heading for a $30 billion-plus valuation The Information : Ilya Sutskever's Startup in Talks to Raise Financing at $30 Billion Valuation Meytal Vaizberg / Globes Online : Ilya Sutskever's SSI raising money at $30b valuation - report Bhuvana Kamath / YourStory.com : OpenAI Co founder Ilya Sutskever's startup seeks over $1B in funding at $30B valuation: Report Aditi Suresh / Analytics India Magazine : OpenAI co-founder Sutskever's Startup Set to Raise $1 Billion: Reports Archanarani / Verdict : SSI in talks to raise more than $1bn Ananya Gairola / Benzinga : Ex-OpenAI Chief Scientist Ilya Sutskever's AI Startup Valued At $30 Billion In Latest Funding Round: Report X: Azeem Azhar / @azeem : Ilya Sutskever"s startup Safe Super Intelligence is closing on a $1bn raise at a $30bn valuation. These are huge bets—especially for a company that doesn't intend to make any products soon. Is this Ilya suggesting that OpenAI isn't on a path to superintelligence faster than Marcelo Lebre / @marcelo_lebre : We should just formalize “gazillion” to refer to AI fundraising - it doesn't make sense anyway and it makes it super clear it's a lot. Ra¢hel / @rachdele : $30 billion valuation, no product “luckily the market has reached a ‘permanently high plateau.’ -irving fisher, 1929” -rachdele, 2025 Sheel Mohnot / @pitdesi : Greenoaks leading $1B+ into @ilyasut's Safe Superintelligence @ $30B $0 revenue & don't intend to sell anything in the near future. Their 1st product will be the safe superintelligence, and will they not do anything else until then. Would love to see the memo :) @_akhaliq : [image] Kate Clark / @kateclarktweets : Greenoaks Capital is leading a $1 billion+ round for Safe Superintelligence, the AI startup founded by ex-OpenAI chief scientist Ilya Sutskever, at a valuation over $30 billion. Scoop: https://www.bloomberg.com/...
Context & Ripple Effects
SSI was launched around a narrowly defined mission—building a safe superintelligence—and then secured its first reported $1B financing in September 2024 at a reported $5B valuation.
This report follows earlier talks at a $20B-plus valuation, indicating that investor pricing for the company was rising before a publicly described product or revenue base emerged in the coverage.
First-order effects
- If completed as reported, the round gives SSI more than $1B of additional funding and installs Greenoaks as its lead financial backer, with a planned $500M commitment.
- A $30B-plus valuation would sharply reprice SSI relative to its September round, increasing the value of existing investors’ stakes and raising expectations for the company’s execution.
Second-order effects
- The reported step-up makes founder pedigree and a focused frontier-AI mission more potent fundraising differentiators, putting pressure on other early-stage labs to show why they merit comparable capital access.
- A large lead check concentrates SSI’s financing relationship with Greenoaks, giving the startup a better-funded position in the contest for scarce technical talent and long-horizon research capacity.
Third-order effects
- If similar rounds continue, frontier-AI development will increasingly be shaped by a small set of investors able to underwrite multibillion-dollar, pre-commercial research efforts rather than by conventional venture funding alone.
- The pattern could widen the gap between a few heavily financed frontier labs and the broader AI startup market, while making valuation discipline more consequential if technical progress or commercialization fails to meet capital-market expectations.
The trend: SSI’s reported financing is another instance of frontier-AI capital concentrating around elite teams pursuing long-duration, compute-intensive research agendas.